Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 7Gastrointestinal 2Lymphoid 1

Conditions

Thrombocytopenia 1Lymphoma 1

Interventions

eltrombopag 3Etoposide 3Cytarabine 3romiplostim 2Platelet Transfusion 2Lenalidomide 2Filgrastim 2Cyclosporine 2Cyclophosphamide 2sodium thiosulfate 1siltuximab 1pegfilgrastim 1ofatumumab 1fludarabine phosphate 1etoposide phosphate 1avatrombopag 1alvocidib 1Vorinostat 1Vitamin E 1Vincristine 1Topotecan 1Thioguanine 1Surveys and Questionnaires 1Rituximab 1Ritonavir 1Radiotherapy 1Quality of Life 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × avatrombopag × Lymphoid × Clear all
NCT04797182 2021-03-15

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Sun Yat-sen University

Phase 2 Unknown
46 enrolled
Classical hematologyLymphoid

Lymphoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡